PCSK9 Monoclonal Antibodies for the Primary and Secondary Prevention of Cardiovascular Disease

Abstract

This article is the Russian translation of the Plain Language Summary (PLS) of the Cochrane Review previously published in the Cochrane Database of Systematic Reviews. Original publication: Schmidt AF, Carter J-PL, Pearce LS, Wilkins JT, Overington JP, Hingorani AD, Casas J. PCSK9 monoclonal antibodies for the primary and secon dary prevention of cardiovascular disease. Cochrane Database of Systematic Reviews. 2020, Issue 10. Art. No.: CD011748. https://doi.org/10.1002/14651858.CD011748.pub3

Keywords

• pcsk9 monoclonal antibodies
• cardiovascular disease
• prevention
• alirocumab
• evolocumab
• cochrane review